Work

Cancer metabolism as a central driving force of glioma pathogenesis

Year: 2016

Type: article

Source: Brain Tumor Pathology

DOI: 10.1007/s10014-016-0265-5

Authors: Kenta Masui, Webster K. Cavenee, Paul S. Mischel

Institutions: Tokyo Women's Medical University, University of California San Diego

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Brain Tumor Society, Cell Science Research Foundation, Ben and Catherine Ivy Foundation, Novartis Foundation, Ziering Family Foundation, Tokyo Biochemical Research Foundation, National Institutes of Health, Japan Society for the Promotion of Science, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: The role of metabolic and epigenetic heterogeneity in glioblastoma treatment, G3049806640, The role of mTORC2 in reprogramming cancer cell metabolism, NanoSystems Biology Cancer Center, G6964556866

OpenAlex ID: W2427654690

FWCI: 4.156

Cites: 53

Cited by: 40

Related to: 10